Results 191 to 200 of about 32,634,218 (335)

The identity \(L(E,F)=LB(E,F)\), tensor products and inductive limits

open access: yes, 1989
Summary: The purpose of this article is to extend the study of pairs of locally convex spaces \((E,F)\) such that every continuous linear map from \(E\) into \(F\) is bounded (i.e. maps a 0-nghb in \(E\) in a bounded subset of \(F\)), and to give applications of our results in this direction to the interchangeability of inductive limits and projective ...
Bonet, J., Galbis, A.
openaire   +2 more sources

Patient‐specific pharmacogenomics demonstrates xCT as predictive therapeutic target in colon cancer with possible implications in tumor connectivity

open access: yesMolecular Oncology, EarlyView.
This study integrates transcriptomic profiling of matched tumor and healthy tissues from 32 colorectal cancer patients with functional validation in patient‐derived organoids, revealing dysregulated metabolic programs driven by overexpressed xCT (SLC7A11) and SLC3A2, identifying an oncogenic cystine/glutamate transporter signature linked to ...
Marco Strecker   +16 more
wiley   +1 more source

Composition and morphology of the wear surface of H13 samples a) untreated, b) Hardened, c) AlCrN before wear, d) AlCrN after wear, e) TiAlN before wear f) TiAlN after wear.

open access: green
Saravanan Balakrishnan (22110287)   +5 more
openalex   +1 more source

Apolipoprotein E polymorphism and atherosclerosis.

open access: yesArteriosclerosis, 1988
J. Davignon, R. Gregg, C. Sing
semanticscholar   +1 more source

Predictors of response and rational combinations for the novel MCL‐1 inhibitor MIK665 in acute myeloid leukemia

open access: yesMolecular Oncology, EarlyView.
This study characterizes the responses of primary acute myeloid leukemia (AML) patient samples to the MCL‐1 inhibitor MIK665. The results revealed that monocytic differentiation is associated with MIK665 sensitivity. Conversely, elevated ABCB1 expression is a potential biomarker of resistance to the treatment, which can be overcome by the combination ...
Joseph Saad   +17 more
wiley   +1 more source

Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

open access: yesAnnals of Oncology, 2019
E. Senkus   +6 more
semanticscholar   +1 more source

Feasibility of a ctDNA multigenic panel for non‐small‐cell lung cancer early detection and disease surveillance

open access: yesMolecular Oncology, EarlyView.
Plasma‐based detection of actionable mutations is a promising approach in lung cancer management. Analysis of ctDNA with a multigene NGS panel identified TP53, KRAS, and EGFR as the most frequently altered, with TP53 and KRAS in treatment‐naïve patients and TP53 and EGFR in previously treated patients.
Giovanna Maria Stanfoca Casagrande   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy